Development of an immunoassay test system for diagnostics and differential diagnosis of autoimmune motility disorders of the gastrointestinal tract
DOI:
https://doi.org/10.21638/spbu11.2019.427Abstract
Gastrointestinal motility disorders associated with impaired intestinal innervation have been little studied. Disruptions in the work of parasympathetic and metasympathetic structures can be caused by an autoimmune process both against the receptor apparatus and against peptides that perform mediator functions. In this regard, the development of methods for determining antibodies to the α3-acetylcholine receptor and the gonadoliberin releasing factor, which are involved in the regulation of gastrointestinal motility is relevant. As shown in this article, detection of these autoantibodies in patients with gastrointestinal motility disorders allows one to diagnose autoimmune damage to the peripheral parasympathetic and metasympathetic division of the autonomic nervous system, to conduct differential diagnosis of clinically similar pathological processes and to provide adequate timely treatment aimed at suppressing autoimmune lesions of the autoimmune nervous system and improving the quality of life of patients with peripheral autonomic insufficiency.
Keywords:
autoimmune lesions, autonomic nervous system, ELISA, GnRH, α3-AсhR
Downloads
References
References
Downloads
Published
How to Cite
Issue
Section
License
Articles of "Vestnik of Saint Petersburg University. Medicine" are open access distributed under the terms of the License Agreement with Saint Petersburg State University, which permits to the authors unrestricted distribution and self-archiving free of charge.